To include your compound in the COVID-19 Resource Center, submit it here.

NanoVector: Planted in the nucleus

NanoVector Inc. believes its plant virus-based nanoparticle technology will allow it to deliver drugs precisely inside targeted cells, reducing side effects and improving the efficacy of chemotherapeutics and other drugs.

The technology exploits the chemical sensing ability of the red clover necrotic mosaic virus (RCNMV). When RCNMV enters a host cell via receptor-mediated endocytosis, the reduced levels of calcium and magnesium inside the cell activate the virus and allow

Read the full 680 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers